Lansoprazole
- Product NDC
- 0093-7350
- 11-digit product format
- 000937350
- Labeler code
- 0093
- Product ID
- 0093-7350_cff4a734-b698-4be2-88f2-058914575919
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Teva Pharmaceuticals USA, Inc.
- Application
- ANDA077255
- Marketing category
- ANDA
- Marketing start
- 2009-11-11
- Substance
- LANSOPRAZOLE
- Active strength
- 15 mg/1
- Pharmacologic classes
- Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Lansoprazole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| LANSOPRAZOLE | 15 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 0K5C5T2QPG |
| Rxcui | 311277, 596843 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0093-7350-56 | Lansoprazole | 30 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 30 | | 25 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| MAGNESIUM CARBONATE | INACTIVE INGREDIENT | 0E53J927NA | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA INC] | 14 | |
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| FERROSOFERRIC OXIDE | INACTIVE INGREDIENT | XM0M87F357 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| MAGNESIUM CARBONATE | INACTIVE INGREDIENT | 0E53J927NA | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| POTASSIUM HYDROXIDE | INACTIVE INGREDIENT | WZH3C48M4T | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| SHELLAC | INACTIVE INGREDIENT | 46N107B71O | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [PHYSICIANS TOTAL CARE, INC.] | 4 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0093-7350 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [TEVA PHARMACEUTICALS USA, INC.] | 25 | Current NDC, Legacy NDC, 1 package rows | 20220626_427cf924-be17-47dc-8f77-115fa2f3fe17.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0093-7350-56 | 00093735056 | 30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0093-7350-56) | 2009-11-11 | 0000-00-00 | No | No | Current |